CAP/ACMG proficiency testing for biochemical genetics laboratories: A summary of performance

College of American Pathologists and American College of Medical Genetics

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

PurposeTesting for inborn errors of metabolism is performed by clinical laboratories worldwide, each utilizing laboratory-developed procedures. We sought to summarize performance in the College of American Pathologists' (CAP) proficiency testing (PT) program and identify opportunities for improving laboratory quality. When evaluating PT data, we focused on a subset of laboratories that have participated in at least one survey since 2010.MethodsAn analysis of laboratory performance (2004 to 2014) on the Biochemical Genetics PT Surveys, a program administered by CAP and the American College of Medical Genetics and Genomics. Analytical and interpretive performance was evaluated for four tests: amino acids, organic acids, acylcarnitines, and mucopolysaccharides.ResultsSince 2010, 150 laboratories have participated in at least one of four PT surveys. Analytic sensitivities ranged from 88.2 to 93.4%, while clinical sensitivities ranged from 82.4 to 91.0%. Performance was higher for US participants and for more recent challenges. Performance was lower for challenges with subtle findings or complex analytical patterns.ConclusionUS clinical biochemical genetics laboratory proficiency is satisfactory, with a minority of laboratories accounting for the majority of errors. Our findings underscore the complex nature of clinical biochemical genetics testing and highlight the necessity of continuous quality management.

Original languageEnglish (US)
Pages (from-to)83-90
Number of pages8
JournalGenetics in Medicine
Volume20
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Molecular Biology
Genetic Testing
Total Quality Management
Inborn Errors Metabolism
Pathologists
Genomics
Glycosaminoglycans
Amino Acids
Acids
Surveys and Questionnaires

Keywords

  • analytic sensitivity
  • biochemical genetics
  • clinical sensitivity
  • inborn errors of metabolism
  • proficiency testing

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

College of American Pathologists and American College of Medical Genetics (2018). CAP/ACMG proficiency testing for biochemical genetics laboratories: A summary of performance. Genetics in Medicine, 20(1), 83-90. https://doi.org/10.1038/gim.2017.61

CAP/ACMG proficiency testing for biochemical genetics laboratories : A summary of performance. / College of American Pathologists and American College of Medical Genetics.

In: Genetics in Medicine, Vol. 20, No. 1, 01.01.2018, p. 83-90.

Research output: Contribution to journalArticle

College of American Pathologists and American College of Medical Genetics 2018, 'CAP/ACMG proficiency testing for biochemical genetics laboratories: A summary of performance', Genetics in Medicine, vol. 20, no. 1, pp. 83-90. https://doi.org/10.1038/gim.2017.61
College of American Pathologists and American College of Medical Genetics. CAP/ACMG proficiency testing for biochemical genetics laboratories: A summary of performance. Genetics in Medicine. 2018 Jan 1;20(1):83-90. https://doi.org/10.1038/gim.2017.61
College of American Pathologists and American College of Medical Genetics. / CAP/ACMG proficiency testing for biochemical genetics laboratories : A summary of performance. In: Genetics in Medicine. 2018 ; Vol. 20, No. 1. pp. 83-90.
@article{40a3351bf07343edbc8d00bc6dd5398d,
title = "CAP/ACMG proficiency testing for biochemical genetics laboratories: A summary of performance",
abstract = "PurposeTesting for inborn errors of metabolism is performed by clinical laboratories worldwide, each utilizing laboratory-developed procedures. We sought to summarize performance in the College of American Pathologists' (CAP) proficiency testing (PT) program and identify opportunities for improving laboratory quality. When evaluating PT data, we focused on a subset of laboratories that have participated in at least one survey since 2010.MethodsAn analysis of laboratory performance (2004 to 2014) on the Biochemical Genetics PT Surveys, a program administered by CAP and the American College of Medical Genetics and Genomics. Analytical and interpretive performance was evaluated for four tests: amino acids, organic acids, acylcarnitines, and mucopolysaccharides.ResultsSince 2010, 150 laboratories have participated in at least one of four PT surveys. Analytic sensitivities ranged from 88.2 to 93.4{\%}, while clinical sensitivities ranged from 82.4 to 91.0{\%}. Performance was higher for US participants and for more recent challenges. Performance was lower for challenges with subtle findings or complex analytical patterns.ConclusionUS clinical biochemical genetics laboratory proficiency is satisfactory, with a minority of laboratories accounting for the majority of errors. Our findings underscore the complex nature of clinical biochemical genetics testing and highlight the necessity of continuous quality management.",
keywords = "analytic sensitivity, biochemical genetics, clinical sensitivity, inborn errors of metabolism, proficiency testing",
author = "{College of American Pathologists and American College of Medical Genetics} and Devin Oglesbee and Cowan, {Tina M.} and Marzia Pasquali and Wood, {Timothy C.} and Weck, {Karen E.} and Thomas Long and Palomaki, {Glenn E.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1038/gim.2017.61",
language = "English (US)",
volume = "20",
pages = "83--90",
journal = "Genetics in Medicine",
issn = "1098-3600",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - CAP/ACMG proficiency testing for biochemical genetics laboratories

T2 - A summary of performance

AU - College of American Pathologists and American College of Medical Genetics

AU - Oglesbee, Devin

AU - Cowan, Tina M.

AU - Pasquali, Marzia

AU - Wood, Timothy C.

AU - Weck, Karen E.

AU - Long, Thomas

AU - Palomaki, Glenn E.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - PurposeTesting for inborn errors of metabolism is performed by clinical laboratories worldwide, each utilizing laboratory-developed procedures. We sought to summarize performance in the College of American Pathologists' (CAP) proficiency testing (PT) program and identify opportunities for improving laboratory quality. When evaluating PT data, we focused on a subset of laboratories that have participated in at least one survey since 2010.MethodsAn analysis of laboratory performance (2004 to 2014) on the Biochemical Genetics PT Surveys, a program administered by CAP and the American College of Medical Genetics and Genomics. Analytical and interpretive performance was evaluated for four tests: amino acids, organic acids, acylcarnitines, and mucopolysaccharides.ResultsSince 2010, 150 laboratories have participated in at least one of four PT surveys. Analytic sensitivities ranged from 88.2 to 93.4%, while clinical sensitivities ranged from 82.4 to 91.0%. Performance was higher for US participants and for more recent challenges. Performance was lower for challenges with subtle findings or complex analytical patterns.ConclusionUS clinical biochemical genetics laboratory proficiency is satisfactory, with a minority of laboratories accounting for the majority of errors. Our findings underscore the complex nature of clinical biochemical genetics testing and highlight the necessity of continuous quality management.

AB - PurposeTesting for inborn errors of metabolism is performed by clinical laboratories worldwide, each utilizing laboratory-developed procedures. We sought to summarize performance in the College of American Pathologists' (CAP) proficiency testing (PT) program and identify opportunities for improving laboratory quality. When evaluating PT data, we focused on a subset of laboratories that have participated in at least one survey since 2010.MethodsAn analysis of laboratory performance (2004 to 2014) on the Biochemical Genetics PT Surveys, a program administered by CAP and the American College of Medical Genetics and Genomics. Analytical and interpretive performance was evaluated for four tests: amino acids, organic acids, acylcarnitines, and mucopolysaccharides.ResultsSince 2010, 150 laboratories have participated in at least one of four PT surveys. Analytic sensitivities ranged from 88.2 to 93.4%, while clinical sensitivities ranged from 82.4 to 91.0%. Performance was higher for US participants and for more recent challenges. Performance was lower for challenges with subtle findings or complex analytical patterns.ConclusionUS clinical biochemical genetics laboratory proficiency is satisfactory, with a minority of laboratories accounting for the majority of errors. Our findings underscore the complex nature of clinical biochemical genetics testing and highlight the necessity of continuous quality management.

KW - analytic sensitivity

KW - biochemical genetics

KW - clinical sensitivity

KW - inborn errors of metabolism

KW - proficiency testing

UR - http://www.scopus.com/inward/record.url?scp=85040467208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040467208&partnerID=8YFLogxK

U2 - 10.1038/gim.2017.61

DO - 10.1038/gim.2017.61

M3 - Article

C2 - 28661487

AN - SCOPUS:85040467208

VL - 20

SP - 83

EP - 90

JO - Genetics in Medicine

JF - Genetics in Medicine

SN - 1098-3600

IS - 1

ER -